Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 1.00 |
| ▸ | CA1 | P00915 | 10/20 | 1.00 |
| ▸ | CA12 | O43570 | 7/20 | 1.00 |
| ▸ | CA9 | Q16790 | 6/20 | 1.00 |
| ▸ | CA4 | P22748 | 6/20 | 1.00 |
| ▸ | CA6 | P23280 | 5/20 | 1.00 |
| ▸ | CA5A | P35218 | 5/20 | 1.00 |
| ▸ | CA7 | P43166 | 5/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 1.00 |
| ▸ | F2 | P00734 | 2/20 | 0.67 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | HTR6 | P50406 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2352021 | 0.98 | CA2 (0.96) | CA2CA1CA12CA9CA4 | |
| Hydrochloric Acid SCHEMBL27515376 | 0.96 | CA2 (0.92) | CA2CA1CA12CA9CA4 | |
| SCHEMBL12614485 | 0.89 | CA2 (0.79) | CA2CA1CA12CA9CA4 | |
| Isothiocyanate SCHEMBL29213995 | 0.89 | CA2 (0.79) | CA2CA1CA12CA9CA4 | |
| SCHEMBL9683336 | 0.87 | CA2 (0.77) | CA2CA1CA12CA9CA4 | |
| Benzenesulfonamide SCHEMBL7207114 | 0.85 | CA1 (0.74) | CA2CA1CA12CA9CA4 | |
| Hydrochloric Acid SCHEMBL15193100 | 0.85 | CA2 (0.74) | CA2CA1CA12CA9CA4 | |
| Sulfanilamide SCHEMBL27483111 | 0.85 | CA1 (0.72) | CA2CA1CA12CA9CA4 | |
| SCHEMBL6680951 | 0.84 | HTR6 (0.84) | CA2CA1CA12CA9CA4 | |
| SCHEMBL1804221 | 0.82 | CA2 (0.69) | CA2CA1CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120157773-A | Chimeric antigen receptor, nucleic acid molecule, CAR-Ms and application thereof | 山东大学 | 2025-06-17 | — | — | CN | claimed |
| CN-119823036-A | HYNIC modified 4- (2-aminoethyl) benzenesulfonamide derivative and application thereof | 北京师范大学 | 2025-04-15 | — | — | CN | claimed |
| CN-119632952-A | Preparation method of tumor microenvironment regulation type nano drug delivery system, product and application thereof | 杭州市第一人民医院(西湖大学附属杭州市第一人民医院) | 2025-03-18 | — | — | CN | claimed |
| CN-119264173-A | Si rhodamine derivative for hypoxia imaging and preparation method and application thereof | 河南师范大学 | 2025-01-07 | — | — | CN | claimed |
| CN-119060130-A | Self-assembled nano material for targeting hypoxic tumor cell membrane to prevent exosome from escaping, and preparation method and application thereof | 国家纳米科学中心 | 2024-12-03 | — | — | CN | claimed |
| CN-118315677-B | Wide-temperature-range electrolyte and preparation method and application thereof | 河北省科学院能源研究所 | 2024-10-01 | — | — | CN | claimed |
| CN-118315677-A | Wide-temperature-range electrolyte and preparation method and application thereof | 河北省科学院能源研究所 | 2024-07-09 | — | — | CN | claimed |
| CN-118059250-A | Nanometer medicine for destroying crosstalk and preparation method and application thereof | 中国医学科学院放射医学研究所 | 2024-05-24 | — | — | CN | claimed |
| CN-114614058-B | Thin-layer composite proton exchange membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117732437-A | Preparation and drug target identification application of switchable sulfhydryl functional magnetic silica nanoparticle | 北京青莲百奥生物科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| WO-2002064598-A1 | THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2002-08-22 | — | — | WO | claimed |
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DISCOVERY PARTNERS INTERNATIONAL, INC. | 2002-05-16 | — | — | US | claimed |
| US-6068989-A | Method and dry analytical element for determination of bicarbonate ion in liquid | FUJI PHOTO FILM CO., LTD. (JP) | 2000-05-30 | — | — | US | claimed |
| WO-2000006525-A9 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | HARVARD COLLEGE (US) | 2000-04-20 | — | — | WO | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
| US-5945520-A | RESIN OF SOLID SUPPORT MATRIX, SPACER ARM AND IONIZABLE FUNCTIONALITY; SPECIFICALLY DESIGNED TO BIND THE TARGET COMPOUND FROM AN AQUEOUS SOLUTION AT BOTH A LOW AND HIGH IONIC STRENGTH | MASSEY UNIVERSITY (NZ) | 1999-08-31 | — | — | US | claimed |
| US-5652348-A | SOLID SUPPORT MATRIX, IONIZABLE LIGANDS SELECTED RELATIVE TO TARGET COMPOUND | MASSEY UNIVERSITY (NZ) | 1997-07-29 | — | — | US | claimed |
| EP-0783366-A1 | CHROMATOGRAPHIC RESINS AND METHODS FOR USING SAME | MASSEY UNIVERSITY (NZ) | 1997-07-16 | — | — | EP | claimed |
| WO-1996009116-A1 | CHROMATOGRAPHIC RESINS AND METHODS FOR USING SAME | MASSEY UNIVERSITY (NZ) | 1996-03-28 | — | — | WO | claimed |
| EP-0443560-A2 | HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-08-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DNPEP, LNPEP, NPEPPS | CA2 3928/4885CA1 1001/4885CA12 2200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.